Related Experiment Video
Updated: Mar 8, 2026

13:34
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.7K
Specialty Payment Model Opportunities and Assessment: Oncology Simulation Report
Rand Health Quarterly
|January 14, 2017
Summary
This study simulates a new oncology payment model for Medicare. Care management payments significantly boost practice revenue, but Medicare requires a 4% utilization reduction to break even.
Area of Science:
- Health economics
- Oncology payment reform
- Healthcare policy analysis
Background:
- The Center for Medicare and Medicaid Innovation (CMS) is exploring new payment models for specialty oncology services.
- Simulation analyses were commissioned to assess the potential impacts of a proposed oncology payment model.
Purpose of the Study:
- To simulate the financial and utilization impacts of a novel oncology payment model.
- To inform design decisions for a potential Centers for Medicare & Medicaid Services (CMS) oncology payment model.
Main Methods:
- Analysis of an episode-level dataset from Medicare fee-for-service (FFS) claims for 2010 oncology episodes.
- Modeling a payment structure including FFS, per-beneficiary per-month care management payments, and performance-based payments.
Main Results:
- Care management payments ($960/episode) represent 4% of total spending but increase practice revenue by ~50%.
- Medicare requires a ~4% reduction in utilization/intensity for the program to break even.
- Reducing care management or performance-based payments can lower the break-even threshold.
Conclusions:
- The proposed oncology payment model offers substantial revenue increases for practices.
- Achieving Medicare program break-even necessitates significant practice-level utilization and intensity reductions.
- Model parameters, specifically payment amounts, can be adjusted to influence financial sustainability.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
807
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
807
Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K

